Source:http://linkedlifedata.com/resource/pubmed/id/15209889
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2004-6-22
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0042-9007
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
87 Suppl 2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
93-5
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15209889-Anemia,
pubmed-meshheading:15209889-Clinical Trials as Topic,
pubmed-meshheading:15209889-Erythropoietin,
pubmed-meshheading:15209889-Humans,
pubmed-meshheading:15209889-Neoplasms,
pubmed-meshheading:15209889-Recombinant Proteins,
pubmed-meshheading:15209889-Renal Insufficiency
|
pubmed:year |
2004
|
pubmed:articleTitle |
Medical uses of erythropoietin.
|
pubmed:affiliation |
Consultant Haematologist, The John Radcliffe, Headington, Oxford, UK. tim.littlewood@orh.nhs.uk
|
pubmed:publicationType |
Journal Article,
Review
|